CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
NCT Number: NCT01543386
The aim of this study is to determine if an oral loading-dose of curcumin can improve vascular endothelium reactivity in patients with moderate cardiovascular risk
Looking for future studies?
Notify Me50 year–70 year
All sexes
Interventional
Phase 1 / Phase 2
Clermont-Ferrand, 63003, France
The aim of this study is to determine if an oral loading-dose of curcumin can improve vascular endothelium reactivity in patients with moderate cardiovascular risk
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The aim of this study is to determine if an oral loading-dose of curcumin can improve vascular endothelium reactivity in patients with moderate cardiovascular risk
Time frame: at Visit 1 (Day 0) and visit 2 (Day3/day5)
Time frame: at visit 1 (day 0) and visit 2 (day3/day5)
Time frame: at visit 1 (day 0) and visit 2 (day3/day 5)
University Hospital, Clermont-Ferrand
Other
Effects of Curcumin Loading Dose on Vascular Reactivity of Healthy Middle-aged Smokers
Acronym: CURCUMIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03968900
Behavior, Chemically-Induced Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT07737587
Behavior, Pathologic Processes
Iğdır, Turkey (Türkiye)
View Trial DetailsNCT06191419
Behavior, Chemically-Induced Disorders
Lexington, Kentucky, United States
View Trial DetailsNCT04620915
Behavior, Cancer
Eugene, Oregon, United States
View Trial Details